E-Mail Express

Name:

Company:

E-mail:

Phone:

Oculus reports 50% increase in sales

PETALUMA, Nov. 6, 2008 -- Oculus Innovative Sciences Inc. (NASDAQ: OCLS) reported record revenue of $1.5 million for the second-quarter of its fiscal 2008-2009.

The figure represents a 50 percent increase over revenues of $1 million in the second quarter a year ago. Product revenue was $1.2 million, another record, up 81 percent from $670,000 in the same period last year.

Also during the quarter Oculus reduced operating expenses by $1.7 million to $2 million.

"We posted record second quarter revenue while achieving important milestones for future sales growth," said Oculus president and founder Hoji Alimi, adding that the recent, on-time product launch of Sinopharm in China and expanded distribution infrastructure in Europe, India, Mexico and U.S. contributed to revenue growth.

The Oculus Microcyn platform successfully made its way through Phase II testing.

Oculus, which develops and markets a super-oxidized solution to promote the healing of wounds, employs 56 worldwide, 36 in its Petaluma headquarters. Oculus stock closed at $1.04, up 7 cents.